Table 1

B-cell populations with deletion efficiencies in Notch2IC//CD19Cre+/− and control mice

BM (n = 7)
Spleen (n = 10)
IgM B220low CD43+ pro-BIgM B220low CD43 pre-BB220+ IgM+ IgD immature BB220+ IgM+ IgD+ mature BAA4.1+ IgM+ T BAA4.1+ IgMhigh CD23 T1 BAA4.1+ IgMhigh CD23+ T2 BAA4.1+ IgMlow CD23+ T3 BB220+ CD21int CD23+ Fo BB220+ CD21high CD23 MZ B
Control, mean ± SD, % 8 ± 2 36 ± 12 15 ± 3 20 ± 3 17 ± 8 23 ± 5 40 ± 6 19 ± 3 73 ± 4 8 ± 3 
Notch2IC//CD19Cre+/−, mean ± SD, % 8 ± 2 29 ± 13 18 ± 2 7 ± 3 17 ± 5 39 ± 9 34 ± 10* 11 ± 3 13 ± 4 65 ± 5 
Control, mean ± SD, × 105 1.8 ± 0.6 7.9 ± 2.9 3.1 ± 1.0 4.2 ± 0.5 4.3 ± 1.6 1.4 ± 0.6 2.3 ± 0.7 1.1 ± 0.4 22.0 ± 8.5 2.4 ± 1.2 
Notch2IC//CD19Cre+/−, mean ± SD, × 105 1.4 ± 0.6 5.2 ± 2.1 2.3 ± 0.8 0.9 ± 0.2 5.9 ± 2.6 2.6 ± 1.4* 2.1 ± 0.9 0.7 ± 0.2* 4.2 ± 3.0 17.6 ± 7.8 
Notch2IC//CD19Cre+/−, mean ± SD, % hCD2+ 9 ± 2 9 ± 2 42 ± 4 57 ± 9 58 ± 7 70 ± 9 58 ± 12 49 ± 7 26 ± 8 95 ± 2 
BM (n = 7)
Spleen (n = 10)
IgM B220low CD43+ pro-BIgM B220low CD43 pre-BB220+ IgM+ IgD immature BB220+ IgM+ IgD+ mature BAA4.1+ IgM+ T BAA4.1+ IgMhigh CD23 T1 BAA4.1+ IgMhigh CD23+ T2 BAA4.1+ IgMlow CD23+ T3 BB220+ CD21int CD23+ Fo BB220+ CD21high CD23 MZ B
Control, mean ± SD, % 8 ± 2 36 ± 12 15 ± 3 20 ± 3 17 ± 8 23 ± 5 40 ± 6 19 ± 3 73 ± 4 8 ± 3 
Notch2IC//CD19Cre+/−, mean ± SD, % 8 ± 2 29 ± 13 18 ± 2 7 ± 3 17 ± 5 39 ± 9 34 ± 10* 11 ± 3 13 ± 4 65 ± 5 
Control, mean ± SD, × 105 1.8 ± 0.6 7.9 ± 2.9 3.1 ± 1.0 4.2 ± 0.5 4.3 ± 1.6 1.4 ± 0.6 2.3 ± 0.7 1.1 ± 0.4 22.0 ± 8.5 2.4 ± 1.2 
Notch2IC//CD19Cre+/−, mean ± SD, × 105 1.4 ± 0.6 5.2 ± 2.1 2.3 ± 0.8 0.9 ± 0.2 5.9 ± 2.6 2.6 ± 1.4* 2.1 ± 0.9 0.7 ± 0.2* 4.2 ± 3.0 17.6 ± 7.8 
Notch2IC//CD19Cre+/−, mean ± SD, % hCD2+ 9 ± 2 9 ± 2 42 ± 4 57 ± 9 58 ± 7 70 ± 9 58 ± 12 49 ± 7 26 ± 8 95 ± 2 

BM cells were isolated from one tibia bone per mouse. Percentages within the lymphocyte gate are shown.

*

P <.05 in comparison to control.

P < .001 in comparison to control.

Close Modal

or Create an Account

Close Modal
Close Modal